Loading…
Elevance Health, Inc. is projected to rise to $455.83 by 2027, a +20% move from its current price of $378.36. ELV is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 29 | $370.56 | $378.58 | $386.76 | +0.06% |
| Jul 30 | $367.50 | $378.79 | $390.43 | +0.11% |
| Jul 31 | $365.22 | $379.01 | $393.32 | +0.17% |
| Aug 1 | $363.34 | $379.22 | $395.80 | +0.23% |
| Aug 2 | $361.71 | $379.44 | $398.03 | +0.28% |
| Aug 3 | $360.27 | $379.65 | $400.08 | +0.34% |
| Aug 4 | $358.96 | $379.87 | $401.99 | +0.40% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $358.96 | $379.87 | $401.99 | +0.40% |
| Week 2 | $352.04 | $381.38 | $413.17 | +0.80% |
| Week 3 | $347.14 | $382.91 | $422.35 | +1.20% |
| Week 4 | $343.28 | $384.43 | $430.52 | +1.60% |
| Week 5 | $340.08 | $385.97 | $438.05 | +2.01% |
| Week 6 | $337.33 | $387.50 | $445.14 | +2.42% |
| Week 7 | $334.94 | $389.05 | $451.91 | +2.83% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Elevance Health, Inc. operates as a health benefits company in the United States, with four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It provides a broad array of health plans and services to individual and employer group members, including BlueCard, Medicare, Medicaid, and FEP members, along with pharmacy services and related home delivery.
The company also offers administrative managed care services, specialty and other insurance products, and healthcare-related services across behavioral health, palliative care, virtual care, and data-driven offerings.
Elevance Health, Inc. (ELV) is a health benefits company with a diversified portfolio of segments and services. The stock currently trades around $372.85 and carries a market capitalization of $80.86B, ranking 199. The stock’s 30-day price action sits within a broad range, signaling material volatility and trading opportunity.
A major floor 24.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.5% away) — a key level to hold.
The nearest ceiling, 12.8% above — a clean break opens room to run.
A major ceiling 18.0% above — clearing it would confirm fresh momentum.
Key ELV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ELV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $384.49 | Sell | $383.42 | Sell |
| MA 10 | $391.07 | Sell | $389.00 | Sell |
| MA 20 | $399.72 | Sell | $394.21 | Sell |
| MA 50 | $398.50 | Sell | $389.60 | Sell |
| MA 100 | $359.01 | Buy | $374.46 | Buy |
| MA 200 | $350.60 | Buy | $363.54 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.14 | Neutral |
| Stoch RSI (14) | 16.49 | Buy |
| CCI (20) | -84.63 | Neutral |
| Williams %R (14) | -89.78 | Info |
| MACD (12,26,9) | -3.69 | Sell |
| ROC (12) | -9.07 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 10.22 | Buy |
| TRIX (15) | -0.02 | Sell |
| Awesome (5,34) | -15.54 | Sell |
| Ultimate (7,14,28) | 39.23 | Neutral |
| Momentum (10) | -37.87 | Sell |
| Aroon Osc (25) | -8.00 | Sell |
| Hull MA (9) | 382.95 | Sell |
| ADX (14) | 17.01 | Neutral |
| ATR (14) | 8.07 | Info |
Technical setup shows near-term dynamics with a 30-day range of $319.20 to $435.51, highlighting room for movement around the current level. The RSI(14) is 40, suggesting there is still headroom before overbought conditions develop. The SMA50 sits at $397.98 while the SMA200 is at $349.20, with the current price near support at $372.85 and resistance at $426.79.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $280.74 | $378.36 | $501.79 | 0% | Neutral | |
| $370.58 | $455.83 | $588.17 | +20% | Bullish | |
| $402.94 | $506.45 | $673.58 | +34% | Bullish | |
| $466.22 | $596.46 | $812.34 | +58% | Bullish | |
| $533.87 | $693.69 | $963.88 | +83% | Bullish | |
| $634.59 | $836.26 | $1,182.52 | +121% | Bullish | |
| $720.27 | $961.61 | $1,381.37 | +154% | Bullish | |
| $784.94 | $1,060.78 | $1,545.80 | +180% | Bullish | |
| $839.13 | $1,147.14 | $1,693.85 | +203% | Bullish | |
| $853.24 | $1,179.31 | $1,762.86 | +212% | Bullish | |
| $1,398.46 | $2,030.35 | $3,196.24 | +437% | Bullish | |
| $2,498.50 | $3,939.56 | $6,693.14 | +941% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $280.74 | $378.36 | $443.20 | +0.00% |
| August 2026 | $327.87 | $383.34 | $457.57 | +1.32% |
| September 2026 | $338.69 | $398.50 | $480.55 | +3.95% |
| October 2026 | $345.07 | $408.09 | $496.17 | +2.41% |
| November 2026 | $341.07 | $405.06 | $495.79 | -0.74% |
| December 2026 | $341.78 | $407.49 | $501.79 | +0.60% |
Click any year to see its month-by-month ELV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Elevance Health, Inc.'s 2026 outlook centres on $378.36, within a $280.74 to $501.79 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ELV could reach as high as $588.17, with a base case around $455.83 and support toward $370.58 — roughly +20% from $378.36. Buyers look set to stay in control over this stretch.
Expect ELV to range from $402.94 to $673.58 through 2028. The $506.45 average target implies a +34% move from current prices. That is up +11% on the projected 2027 average. Momentum favours further upside here.
The ELV price prediction for 2029 points to an average of $596.46 (low $466.22, high $812.34) — a potential gain of +58% on today's $378.36. Buyers look set to stay in control over this stretch.
In 2030, ELV is projected to trade between $533.87 and $963.88, averaging $693.69 — a potential gain of +83% from today's $378.36. That is up +16% on the projected 2029 average. Momentum favours further upside here.
Elevance Health, Inc.'s 2031 outlook centres on $836.26, within a $634.59 to $1,182.52 range. That is up +21% on the projected 2030 average. That marks a +121% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ELV could reach as high as $1,381.37, with a base case around $961.61 and support toward $720.27 — roughly +154% from $378.36. Momentum favours further upside here.
Expect ELV to range from $784.94 to $1,545.80 through 2033. The $1,060.78 average target implies a +180% move from current prices. That is up +10% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ELV price prediction for 2034 points to an average of $1,147.14 (low $839.13, high $1,693.85) — a potential gain of +203% on today's $378.36. Momentum favours further upside here.
In 2035, ELV is projected to trade between $853.24 and $1,762.86, averaging $1,179.31 — a potential gain of +212% from today's $378.36. That is up +3% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Elevance Health, Inc.'s 2040 outlook centres on $2,030.35, within a $1,398.46 to $3,196.24 range. That is up +72% on the projected 2035 average. That marks a +437% change versus current levels. Momentum favours further upside here.
By 2050, ELV could reach as high as $6,693.14, with a base case around $3,939.56 and support toward $2,498.50 — roughly +941% from $378.36. Buyers look set to stay in control over this stretch.
Investing $1,000 in ELV today (≈ 2.642986 ELV) could be worth
$10,412.21
+$9,412.21 (+941%) by 2050 · US Dollar
Based on the average projected ELV price of $3,939.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ELVwould be worth at today's price.
$1,000 invested in ELV on Jul 28, 2025 (≈ 3.496748 ELV) would be worth
$1,323.03
+$323.03 (+32.3%) today · 1.32× · US Dollar
Based on a ELV entry price of $285.98 vs. today's $378.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $382.23 | $989.88 | -1.0% |
| 1 month ago | $395.18 | $957.44 | -4.3% |
| 3 months ago | $362.74 | $1,043.06 | +4.3% |
| 6 months ago | $341.85 | $1,106.8 | +10.7% |
| 1 year ago | $285.98 | $1,323.03 | +32.3% |
| All time (5.0y) ago | $384.33 | $984.47 | -1.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ELV forecast.
Our base-case forecast reaches $760.00 around 2031.
Implied market cap at $760.00: $164.82B
The multi-year forecast points to meaningful upside ahead. The 2026 average price is $372.85 with a max of $501.38 and a min of $280.74; ROI is 0% in 2026 and sentiment is neutral. By 2030, the average rises to $666.04 with a max of $941.54 and a min of $505.55, delivering an 78.6% ROI and bullish sentiment.
In 2040, the average is $1,914.56 and the max $3,095.34, with a 413.5% ROI and bullish sentiment. By 2050, the average reaches $3,688.86 and the max $6,470.29, for an 889.4% ROI and bullish sentiment. Throughout these years, the outlook remains bullish, but these figures are estimates and not guarantees.
Tap a question to reveal the answer.
The forecast for 2030 shows a min of $505.55, an avg of $666.04, and a max of $941.54, with a 78.6% ROI and bullish sentiment.
The long-range forecast shows rising average prices and positive ROI through 2030, 2040, and 2050, with bullish sentiment in later years. However, these are estimates and not guarantees.
According to the forecast, the max for 2030 is $941.54, but the max for 2031 is $1,151.72, indicating it could surpass $1,000 in 2031.
Current price is $372.85 and market cap is $80.86B.
The 30-day range is $319.20 to $435.51, RSI(14) is 40, SMA50 is $397.98, SMA200 is $349.20, with support at $372.85 and resistance at $426.79.
Elevance Health, Inc. Community Discussion
0Share your Elevance Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.